UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 31, 2026
Sale
Calculated transaction value
$246.84K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 28, 2026
Public filing date
Aug 31, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$515.46
Aug 28, 2026
Close before public filing
$515.46
Aug 28, 2026
Return since public filing
-3.56%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 480 shares @ $514.26
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000131
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.2M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 28, 2026 | $1.29M |
| United Therapeutics Corp UTHR Current | Sale | Aug 28, 2026 | $246.84K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $840.2K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $1.23M |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $768.42K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $697.42K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $213.91K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $390.74K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $149.17K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $270.08K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $3.14K |
| United Therapeutics Corp UTHR | Sale | Aug 28, 2026 | $104.88K |
| United Therapeutics Corp UTHR | Exercise | Aug 28, 2026 | $0 |